Navi
Right
 
Skip Navigation LinksHome Research report list Pharma & Healthcare Healthcare Global Intravenous (IV) Iron Drugs Market DataPack - 2016 Edition
 
Social
Global Intravenous (IV) Iron Drugs Market DataPack - 2016 Edition
Format : Pdf (Instant Download)
Date: 06, September 2016 | Pages: 56
Social
 
Electronic Access - Single User License
Tool
USD 450
Electronic Access - Corporate User License
Tool
USD 550
Hard Copy - Mail Delivery
Tool
USD 500
 
   
 

The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research.

 

The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.

 

It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.

 

It also explores the competitive landscape of the respective market with focus on major players.

 

The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.

 

Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.

 

We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.

 

Global Iron Product Market by Value (2011-2015)
Global Iron Products Market Share by Segment (2015)
Global I.V. Iron Drugs Market by Value (2010-2015)
Global I.V. Iron Drugs Market by Product (2010-2015)
Global I.V. Iron Drugs Market Share by Product (2015)
European I.V. Iron Drug Market by Value (2010-2015)
European I.V. Iron Drug Market by Product (2010-2015)
European I.V. Iron Drug Market Share by Product (2015)
The US I.V. Iron Drug Market by Value (2010-2015)
The US I.V. Iron Drug Market by Product (2010-2015)
The US I.V. Iron Drug Market Share by Product (2015)
The US Non-dialysis I.V. Iron Drug Market Volume (2010-2015)
The US Non-dialysis I.V. Iron Drug Market Share by Product (2015)
Global Dialysis Patient Population (2007-2015E)
Global Dialysis Patients by Type (2014)
Global Health Care Expenditure Per Capita (2007-2015E)
The US Healthcare Expenditure Per Capita (2007-2015E)
Global Ageing Population (2006-2015E)
Global Urban Population (2007-2015E)
Prevalence of Iron Deficiency in Women in the US
The US Female Population (2007-2015E)
Global Life Expectancy Rate (2007-2015E)
Global Spending on Medicines (2010-2020E)
The US Spending on Medicine (2007-2015)
Global ERSD Patients (2009-2020E)
Global Addressable Patients for Feraccru by Underlying Disease - Developed World
Galenica’s Net Sales Share by Business Segments (2015)
Galenica’s Net Sales Share by Region (2015)
Galenica’s Net Sales and Net Profit (2011-2015)
AMAG Pharmaceuticals’ Revenue and Net Income (2011-2015)
Allergan Plc.’s Net Sales Business Segment (2015)
Allergan Plc.’s Revenue and Net Income (2011-2015)
Global I.V. Iron Drug Market Forecast (2014-2019E)
Risk Factors for CKD
Emerging Non-Intravenous Therapies for Anemia Management
Comparison between Injectafer® and Venofer®
Summary of Feraccru vs. IV Iron Profile
Dependent & Independent Variables (2011-2015)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Global Iron Product Market by Value (2011-2015)
Global Iron Products Market Share by Segment (2015)
Global I.V. Iron Drugs Market by Value (2010-2015)
Global I.V. Iron Drugs Market by Product (2010-2015)
Global I.V. Iron Drugs Market Share by Product (2015)
European I.V. Iron Drug Market by Value (2010-2015)
European I.V. Iron Drug Market by Product (2010-2015)
European I.V. Iron Drug Market Share by Product (2015)
The US I.V. Iron Drug Market by Value (2010-2015)
The US I.V. Iron Drug Market by Product (2010-2015)
The US I.V. Iron Drug Market Share by Product (2015)
The US Non-dialysis I.V. Iron Drug Market Volume (2010-2015)
The US Non-dialysis I.V. Iron Drug Market Share by Product (2015)
Global Dialysis Patient Population (2007-2015E)
Global Dialysis Patients by Type (2014)
Global Health Care Expenditure Per Capita (2007-2015E)
The US Healthcare Expenditure Per Capita (2007-2015E)
Global Ageing Population (2006-2015E)
Global Urban Population (2007-2015E)
Prevalence of Iron Deficiency in Women in the US
The US Female Population (2007-2015E)
Global Life Expectancy Rate (2007-2015E)
Global Spending on Medicines (2010-2020E)
The US Spending on Medicine (2007-2015)
Global ERSD Patients (2009-2020E)
Global Addressable Patients for Feraccru by Underlying Disease - Developed World
Galenica’s Net Sales Share by Business Segments (2015)
Galenica’s Net Sales Share by Region (2015)
Galenica’s Net Sales and Net Profit (2011-2015)
AMAG Pharmaceuticals’ Revenue and Net Income (2011-2015)
Allergan Plc.’s Net Sales Business Segment (2015)
Allergan Plc.’s Revenue and Net Income (2011-2015)
Global I.V. Iron Drug Market Forecast (2014-2019E)
Risk Factors for CKD
Emerging Non-Intravenous Therapies for Anemia Management
Comparison between Injectafer® and Venofer®
Summary of Feraccru vs. IV Iron Profile
Dependent & Independent Variables (2011-2015)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

One can also purchase any particular sections from this report. Please send us an email to info@konceptanalytics.com with your order details.
 
 
About Us    |    PRESS RELEASES    |    RESEARCH REPORTS    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.